Literature DB >> 21604195

Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Anita Caruso1, Cristina Vigna, Valentina Bigazzi, Carlo Leone, Gabriella Maggi, Aline Martayan, Fabio M Sega, Francesco Cognetti, Antonella Savarese.   

Abstract

The aim of the study was to evaluate factors associated with early withdrawal from oncogenetic counseling. A comparison of psycho-social and personality characteristics of two samples of subjects, attendees and withdrawers was carried out. Self-report questionnaires were completed by 112 individuals who had completed counseling and to 56 individuals who withdrew from it. Individuals with few children (OR. 1,724; p = 0,017; CI = 1,101-2,700), a lower number of cancer affected relatives (OR. 1,301; p = 0,000; CI = 1,145-1,479), and with a lower hypomanic scale score (OR. 1,070; p = 0,004; CI = 1,022-1,121), were more likely to withdraw from counseling. It is important for the counselees to draw more attention to the fact that their cancer risk management and prevention is as fundamental as that of their children. Also, it is important to highlight the fact that having less cancer affected relatives does not necessarily mean being at lower risk. In conclusion, that subjects with low levels of psychological and emotional energy are those who probably need greater psychological support during the decision making process. We deem necessary that psychologists, involved in genetic counseling, investigate these aspects during their sessions in order to implement suitable interventions of psychological support during the entire counseling process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604195     DOI: 10.1007/s10689-011-9454-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

1.  [Personality traits of women participating in a breast cancer prevention trial].

Authors:  Gemma Martino; Cristina Bellati; Alberto Cola; Gabriella Galperti; Vittorio Krogh; Simona Luci; Milena Raimondi
Journal:  Epidemiol Prev       Date:  2002 Mar-Apr       Impact factor: 1.901

2.  Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.

Authors:  K A Donovan; D C Tucker
Journal:  J Behav Med       Date:  2000-02

3.  Psychosocial impact of the lack of information given at referral about familial risk for cancer.

Authors:  Alison Metcalfe; Julie Werrett; Lucy Burgess; Collette Clifford
Journal:  Psychooncology       Date:  2007-05       Impact factor: 3.894

4.  Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal.

Authors:  M Federico; A Maiorana; L Mangone; D Turchetti; B Canossi; L Cortesi; R Romagnoli; V Silingardi
Journal:  Breast Cancer Res Treat       Date:  1999-06       Impact factor: 4.872

5.  Withdrawal from genetic counselling for cancer.

Authors:  Eveline Bleiker; Gea Wigbout; Anja van Rens; Senno Verhoef; Laura Van't Veer; Neil Aaronson
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

6.  The impact of genetic counseling on knowledge and emotional responses in Spanish population with family history of breast cancer.

Authors:  Esther Cabrera; Ignacio Blanco; Carmen Yagüe; Adelaida Zabalegui
Journal:  Patient Educ Couns       Date:  2009-11-30

7.  Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.

Authors:  C Foster; D G R Evans; R Eeles; D Eccles; S Ashley; L Brooks; T Cole; J Cook; R Davidson; H Gregory; J Mackay; P J Morrison; M Watson
Journal:  Genet Test       Date:  2004

8.  The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.

Authors:  Katarina M Sussner; Hayley S Thompson; Lina Jandorf; Tiffany A Edwards; Andrea Forman; Karen Brown; Nidhi Kapil-Pair; Dana H Bovbjerg; Marc D Schwartz; Heiddis B Valdimarsdottir
Journal:  Psychooncology       Date:  2009-09       Impact factor: 3.894

9.  Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout; Margreet G E M Ausems
Journal:  Genet Med       Date:  2007-11       Impact factor: 8.822

10.  A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.

Authors:  Claire E Wakefield; Bettina Meiser; Judi Homewood; Alan Taylor; Margaret Gleeson; Rachel Williams; Kathy Tucker
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

View more
  1 in total

1.  Should I Perform Genetic Testing? A Qualitative Look into the Decision Making Considerations of Religious Israeli Undergraduate Students.

Authors:  Merav Siani; Orit Ben-Zvi Assaraf
Journal:  J Genet Couns       Date:  2016-03-15       Impact factor: 2.537

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.